Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

bioAffinity Technologies, Inc. (BIAF) vs ENDRA Life Sciences Inc. (NDRA)

bioAffinity Technologies, Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. bioAffinity Technologies, Inc. and ENDRA Life Sciences Inc. are of similar size ($9.0M and $8.9M). ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −257.3%) and the lower return on invested capital (−539.9% vs −408.7%). Across the 16 metrics below, ENDRA Life Sciences Inc. leads on 11 and bioAffinity Technologies, Inc. on 5.

Valuation

Metric BIAF NDRA Diagnostics & Research median
P/E n/m n/m 33.95
P/S 0.47 22.35 4.87
P/B 0.73 1.27 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 0.15 7.61 5.66
Earnings yield (1,380.14%) (104.64%) (1.75%)
Free cash flow yield (418.18%) (98.06%) (0.13%)

Profitability

Metric BIAF NDRA Diagnostics & Research median
Gross margin 34.61% 0.00% 50.89%
Operating margin (209.82%) 0.00% (8.57%)
Net margin (257.33%) 0.00% (6.37%)
Free cash flow margin (195.90%) 0.00% 0.00%
Return on equity (1,860.15%) (152.04%) (2.92%)
Return on assets (245.51%) (110.08%) (6.71%)
Return on invested capital (408.67%) (539.89%) 0.00%

Growth

Metric BIAF NDRA Diagnostics & Research median
Revenue growth (TTM) (23.18%) — 7.69%
EPS growth (last fiscal year) 61.55% 84.32% —
Revenue growth, 5-year CAGR — — 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIAF NDRA Diagnostics & Research median
Debt to equity 0.15 0.00 0.11
Current ratio 1.44 7.10 2.02
Net debt to EBITDA 0.57 0.14 0.78

Dividend

Metric BIAF NDRA Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — 0.00 0.00

Size

Metric BIAF NDRA Diagnostics & Research median
Market cap 9.00m 8.89m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack